Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience
dc.contributor.author | Tural, Deniz | |
dc.contributor.author | Olmez, Omer Fatih | |
dc.contributor.author | Sumbul, Ahmet Taner | |
dc.contributor.author | Artac, Mehmet | |
dc.contributor.author | Ozhan, Nail | |
dc.contributor.author | Akar, Emre | |
dc.contributor.author | Cakar, Burcu | |
dc.date.accessioned | 2024-02-23T14:45:26Z | |
dc.date.available | 2024-02-23T14:45:26Z | |
dc.date.issued | 2020 | |
dc.department | NEÜ | en_US |
dc.description | Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) -- FEB 13-15, 2020 -- San Francisco, CA | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/17435 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000529525900480 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Clinical Oncology | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience | en_US |
dc.type | Conference Object | en_US |